Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Weiss

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Nature Neuroscience|April 26, 2016
Control of glioblastoma tumorigenesis by feed-forward cytokine signalingArezu Jahani-Asl, Hang Yin, Vahab D Soleimani, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating GlioblastomaSina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of GlioblastomaXueqing Lun, J Connor Wells, Natalie Grinshtein, et al.
Cell Chemical Biology|June 28, 2023
Chemical genomics reveals targetable programs of human cancers rooted in pluripotencyLuca Orlando, Yannick D Benoit, Jennifer C Reid, et al.
Neuro-Oncology|April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycinFranz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
ACS Synthetic Biology|February 18, 2022
Making Security Viral: Shifting Engineering Biology Culture and PublishingRebecca Mackelprang, Katarzyna P Adamala, Emily R Aurand, et al.
Journal of Medicinal Chemistry|February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic CancerAndrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2019
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environmentsYaoqing Shen, Cameron J Grisdale, Sumaiya A Islam, et al.
Neuro-Oncology|April 17, 2020
In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitorsAlexandra K Bohm, Jessica DePetro, Carmen E Binding, et al.
Elife|January 11, 2021
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survivalPaul Guilhamon, Charles Chesnelong, Michelle M Kushida, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Nature Neuroscience|April 26, 2016
Control of glioblastoma tumorigenesis by feed-forward cytokine signalingArezu Jahani-Asl, Hang Yin, Vahab D Soleimani, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating GlioblastomaSina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of GlioblastomaXueqing Lun, J Connor Wells, Natalie Grinshtein, et al.
Cell Chemical Biology|June 28, 2023
Chemical genomics reveals targetable programs of human cancers rooted in pluripotencyLuca Orlando, Yannick D Benoit, Jennifer C Reid, et al.
Neuro-Oncology|April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycinFranz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
ACS Synthetic Biology|February 18, 2022
Making Security Viral: Shifting Engineering Biology Culture and PublishingRebecca Mackelprang, Katarzyna P Adamala, Emily R Aurand, et al.
Journal of Medicinal Chemistry|February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic CancerAndrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2019
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environmentsYaoqing Shen, Cameron J Grisdale, Sumaiya A Islam, et al.
Neuro-Oncology|April 17, 2020
In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitorsAlexandra K Bohm, Jessica DePetro, Carmen E Binding, et al.
Elife|January 11, 2021
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survivalPaul Guilhamon, Charles Chesnelong, Michelle M Kushida, et al.
Pageof 9